Is This Nvidia's Next Big Invention?
Nvidia helped trigger a historic AI boom that minted 600,000 millionaires in America. It's now working on a new tech that could be even bigger than AI. According to Bank of America, "this [technology] could be the biggest revolution for humanity since discovering fire."
| Open | 206.50 | Prev Close | 206.92 |
| High | 207.70 | Low | 205.34 |
| Volume | 8,473,622 | Volume (Avg) | 8,704 |
| 52 Week High | 207.81 | 52 Week Low | 136.50 |
| Market Cap | 494.7B | PE Ratio | 19.82 |
General
| Name | Johnson & Johnson |
| Ticker | JNJ |
| Exchange | NYSE |
| Sector | Healthcare |
| Industry | Drug Manufacturers - General |
| Currency | USD |
| Country | USA |
| Fiscal Year End | December |
| Full Time Employees | 138,100 |
About Johnson & Johnson
Johnson & Johnson, together with its subsidiaries, engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide. It operates in two segments, Innovative Medicine and MedTech. The Innovative Medicine segment offers products for various therapeutic areas, such as immunology, including rheumatoid arthritis, psoriatic arthritis, inflammatory bowel disease, and psoriasis; infectious diseases comprising HIV/AIDS; neuroscience, consisting of mood disorders, neurodegenerative disorders, and schizophrenia; oncology, such as prostate cancer, hematologic malignancies, lung cancer, and bladder cancer; cardiovascular and metabolism, including thrombosis, diabetes, and macular degeneration; and pulmonary hypertension comprising pulmonary arterial hypertension through retailers, wholesalers, distributors, hospitals, and healthcare professionals for prescription use. The MedTech segment provides electrophysiology products to treat heart rhythm disorders; the heart recovery portfolio, which includes technologies to treat severe coronary artery disease requiring high-risk PCI or AMI cardiogenic shock; circulatory restoration products for the treatment of calcified coronary artery and peripheral artery diseases; and neurovascular care that treats hemorrhagic and ischemic stroke. This segment offers an orthopaedics portfolio that includes products and enabling technologies that support hips, knees, trauma, spine, sports, and other; surgery portfolios comprising advanced and general surgery technologies, as well as solutions for breast aesthetics and reconstruction; contact lenses under the ACUVUE brand; and TECNIS intraocular lenses for cataract surgery. It distributes its products to wholesalers, hospitals, and retailers, as well as physicians, nurses, hospitals, eye care professionals, and clinics. The company was founded in 1886 and is based in New Brunswick, New Jersey.
Highlights
| Analyst Target | 207.41 |
| Market Cap | 494,724,600,000 |
| PE Ratio | 19.82 |
| PEG Ratio | 1.12 |
| EBITDA | 31,921,999,872 |
Valuation
| Trailing PE | 19.99 |
| Forward PE | 17.99 |
| Price/Sales (Trailing 12 Mt.) | 5.41 |
| Price/Book (Most Recent Quarter) | 6.29 |
Technicals
| Beta | 0.35 |
| 52 Week High | 207.81 |
| 52 Week Low | 136.50 |
| 50 Day Average | 7.34% |
| 200 Day Average | 21.26% |
Dividend
Johnson & Johnson pays out a dividend of $5.19 per share, with a dividend yield of 2.53%.
JNJ's next dividend payment will be made to shareholders on December 9, 2025.
They pay out 84.80% of their earnings out as a dividend.
Recent Dividends
| Dec 9, 2025 | $1.30 |
| Sep 9, 2025 | $1.30 |
| Jun 10, 2025 | $1.30 |
| Mar 4, 2025 | $1.24 |
| Dec 10, 2024 | $1.24 |
| Sep 10, 2024 | $1.24 |
| Jun 4, 2024 | $1.24 |
| Mar 5, 2024 | $1.19 |
Cathie Wood Dumps $2.4 Million Worth Of Tesla Stock, Doubles Down On These AI Stocks
Cathie Wood-led Ark Invest made significant trades involving Tesla, Pony AI, TSMC, and Baidu, highlighting their strategic positioning in tech & AI sectors.
US air travelers without REAL IDs will be charged a $45 fee
Air travelers in the U.S. without a will be charged a $45 fee beginning in February, the Transportation Security Administration announced Monday.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Silver Breaks Out In A Short Squeeze, Rising Yields In Japan Hits Stocks and Bitcoin
Rising Yields In Japan
16 Stocks To Buy If You Want To Escape The AI Hype
Bank of America is pointing investors toward 16 overlooked stocks with strong fundamentals and no direct ties to the AI boom—offering a safer path beyond the hype.
The Smart Money Copper Trade - Ad
Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.
Chuck Schumer Says 41-Day Shutdown Has Exposed Trump's 'Cruelty,' Accuses President Of Holding Innocent Kids, Veterans As 'Political Hostages'
Schumer condemns Trump's 'cruelty' behind longest shutdown in U.S. history, as thousands of Americans suffer from furloughs and disrupted services.
Trump commutes prison sentence for former private equity executive David Gentile
HALLANDALE BEACH, Fla. (AP) — President has commuted the prison sentence of former investment manager David Gentile, who was convicted of defrauding investors — the latest in a Trump has taken in .
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Ukrainian Naval Drones Cripple Two Russian Oil Tankers In Black Sea, Disrupt Moscow's Shadow‑Fleet Operations
Ukrainian naval drones struck 2 sanctioned tankers in Black Sea, critically damaging both and crippling a key Russian oil‑transport route.
Officer Injured By January 6 Predicts Trump Will Flee US After 2026 Elections: 'He'll Be Hopping on That Qatari Jet to Saudi Arabia'
Former District of Columbia Metro police officer Michael Fanone has speculated that President Trump might leave the U.S. after the 2026 elections.
The Smart Money Copper Trade - Ad
Quebec discovery. Strong grades. Roads and hydro in place. Funding secured for a busy drill calendar. Each assay can build scale and tighten the window for early entries as EVs and data centers pull harder on copper. Do not wait.
These are the 37 donors helping pay for Trump's $300 million White House ballroom
WASHINGTON (AP) — President Donald Trump says his $300 million White House ballroom will be paid for “100% by me and some friends of mine.”
How Tyson's Chicken Business Will Offset Beef Weakness
Tyson shares rise as pricing catch-up expected to ease cost pressures; chicken strength offsets beef headwinds amid stable feed costs.
Copper, Silver, Gold, Tungsten - This Nevada Play Offers Multiple Shots on Goal - Ad
Most early-stage resource opportunities rely on one metal. This one doesn't. The Walker Lane belt hosts copper, silver, gold, and tungsten - and recent results across the district confirm all four. This startup has stepped in with multi-metal exposure, giving investors several potential ways to capture upside.
China's car sales slow in October as some trade-in subsidies, tax breaks are phased out
BANGKOK (AP) — China's passenger car sales slowed in October, even for electric vehicle makers BYD and Tesla, as automakers cut prices to compete in an overcrowded market, an industry association said Tuesday.
Joan Branson, wife of British billionaire Richard Branson, dies at 80
Joan Branson, the wife of British billionaire Richard Branson, has died at age 80.
The Next Biggest Bull Run In Over 50 Years - Ad
Gold has hit all-time highs, breaking $4,000 an ounce - but history shows it could be on the verge of its biggest bull run in over half a century... triggered by a likely major event, eerily similar to what happened in the 1970s. (It's NOT inflation or anything you're likely expecting.) Now, a top analyst says you can capture ALL of the upside without touching a risky miner or a boring exchange-traded fund. He sees extraordinary potential gains long term with very little risk.
Trump-Pardoned Ponzi Schemer Faces 37-Year Sentence For $44 Million COVID Scam
A previously convicted Ponzi schemer who had received a pardon from President Trump is heading back to prison due to involvement in a new fraudulent scheme.
Watchdog group Public Citizen demands OpenAI withdraw AI video app Sora over deepfake dangers
The tech industry is moving fast and breaking things again — and this time it is humanity’s shared reality and control of our likeness before and after death — thanks to artificial intelligence image-generation platforms .
Weiss Gold Veteran Makes Shocking New Call - Ad
Weiss expert Sean Brodrick went out on a limb last year and declared a historic event would send the yellow metal to $3,150. People laughed at him at the time, but he was off by just two days. Now, Sean has a shocking new prediction for gold ... and reveals a little-known way to get ahead of this bull market.
Swiss prosecutors target Credit Suisse, now part of UBS, over Mozambique money laundering case
GENEVA (AP) — Swiss authorities on Monday said they have indicted a former official at Credit Suisse — now part of Swiss banking titan UBS — for alleged money laundering in a case involving state companies in Mozambique, and charged the bank with not doing enough to stop it.
Nvidia, Dell, Coinbase, Gorilla Technology And Archer Aviation: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed lower on Monday, with the Dow slipping 1.2% to 46,590.24, the S&P 500 easing 0.92% to 6,672.41, and the Nasdaq dipping 0.84% to 22,708.07. These are the top stocks that gained the attention of retail traders and investors through the day:
$270,000 Drug. One Competitor. Billion-Dollar Market. - Ad
Phase 3 trial targets recurrent pericarditis with an oral therapy that could disrupt the only approved treatment. And their heart failure program launches in 2026.
Silver Soars To Record Highs: It's Up 95% In 2025, The Best Year Since 1979
Silver prices surge over 5% as investors rush to secure metal amid tight supplies and global shortage concerns, driving up stocks and mining equities.
Elon Musk Says SpaceX Will Carry '99% Of All Earth Payload' Once Starship Flies Daily
Elon Musk says SpaceX will handle nearly all of Earth's orbital payloads in the coming years as Starship development continues.
Trump Just Signed s.1582 Into Law - Now the Countdown Begins... - Ad
A quiet shift in U.S. law has just authorized private companies to mint a new form of government-authorized money called the "Dollar 2.0"... and the next major mint hits on December 18. Investors who make the right moves before then could make up to 40X by 2032...
Why Is Occidental Petroleum Stock Gaining Tuesday?
Analysts highlight OXY's robust earnings, production guidance, and expanded resource base as key growth drivers.
Trump Bars South Africa From 2026 G20 Summit In Florida, Freezes Aid Over 'White Genocide'
President Donald Trump directed that South Africa will not be invited to the 2026 G20 Summit in Miami, Florida. He also declared that all U.S. payments and subsidies to the country would be immediately suspended.
Is This Nvidia's Next Big Invention? - Ad
Nvidia helped trigger a historic AI boom that minted 600,000 millionaires in America. It's now working on a new tech that could be even bigger than AI. According to Bank of America, "this [technology] could be the biggest revolution for humanity since discovering fire."
California revokes 17,000 driver's licenses. But the state disputes it is over immigration concerns
California plans to revoke 17,000 commercial driver’s licenses given to immigrants after the Trump administration raised concerns about people in the country illegally receiving licenses to drive a semitruck or a bus. But Gov. Gavin Newsom said that isn't the reason.
AT&T reached a $177M data breach settlement. What consumers should know about claiming their money
NEW YORK (AP) — AT&T has reached a combined $177 million settlement over two . And impacted consumers have a little over a month left to file a claim for their chunk of the money.
Is Big Pharma's Next Target Already in Play? - Ad
A small biotech may have cracked one of medicine's biggest problems-how to deliver cancer drugs safely and effectively. With patented technology and promising early data, it's already catching the attention of Big Pharma.
Auto Industry Faces 'EV Winter' Amid Policy Shifts and Supply Chain Woes
The US auto industry is currently facing a myriad of obstacles that are posing a threat to the expansion of EVs.
Cathie Wood Bets Big On These Stocks As Bitcoin, Ethereum Crash —Dumps Instagram Rival
On Tuesday, Cathie Wood-led Ark Invest made significant trades, notably increasing its holdings in Bullish (NYSE:BLSH), Coinbase Glo
The Smart Money Copper Trade - Ad
Only one lines up grade, scale potential, and Quebec power like this. Insider alignment is real. Stepouts are opening new zones. With EVs and grid buildouts rising, this could be the timely copper idea you have been waiting for.
Trump's $2,000 Tariff Dividend Stumbles On Math: Cost Far Exceeds Revenue
Trump's $2,000 tariff rebate plan faces a major math gap, with estimated costs up to $606.8B—far exceeding tariff revenues in 2025 and 2026, says the Tax Foundation.
Piper Sandler Set For Best-In-Class Growth As Banking Cycles Turn: Analyst
Piper Sandler (PIPR) upgraded to Buy by Goldman Sachs with a target price of $386, projecting an 18% upside.
The $43B Big Pharma Story is Starting Over-With a New Player - Ad
Big Pharma once paid $43B for a small biotech with a similar platform. Now, a new company is following that same playbook, leveraging its patented delivery technology to attract partnerships and near-term revenue potential.
Rand Paul Slams GOP's Shift From Fiscal Conservatism: They Voted To Add '$5 Trillion' To The Debt Ceiling — Calls It 'Decimation'
Sen. Rand Paul (R-Ky.) slammed the Republican Party for abandoning the fiscal discipline it once championed, while accusing his colleagues of embracing massive governmental deficits and greenlighting spending levels they previously opposed.
Information, charts or examples are for illustration and educational purposes only and not for individualized investment management This message contains commercial elements, such as advertising. We only send these offers to those who have opted in to our newsletter. Past performance is not indicative of future results. For these reasons we strongly suggest trading in a DEMO/Simulated account. The information provided by us is for educational and informational purposes only. We make no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended and have not determined if the statements and opinions of the advertiser are accurate, correct or truthful. If you use, act upon or make decisions in reliance on information contained or any external source linked within it, you do so at your own peril and agree to hold us, our officers, directors, shareholders, affiliates and agents without fault.